Core Laboratories Inc
CLB
Market Cap$736.33M
Close$
$0.23
98.5% downside
Current Fair Value
98.5% downsideOvervalued by 98.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $736.33 Million |
|---|---|
| Enterprise Value | $900.48 Million |
| Dividend Yield | $0.04 (0.25%) |
| Earnings per Share | $0.5 |
| Beta | 0.75 |
| Outstanding Shares | 46,899,863 |
| Avg 30 Day Volume | 389,872 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 31.05 |
|---|---|
| PEG | -13.76 |
| Price to Sales | 1.61 |
| Price to Book Ratio | 4.02 |
| Enterprise Value to Revenue | 1.79 |
| Enterprise Value to EBIT | 19.43 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.92 |
Revenue Sources
No data
ESG Score
No data
About Core Laboratories N.V.
4,700 employeesCore Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...